These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16879225)

  • 1. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis.
    Van de Wouwer M; Plaisance S; De Vriese A; Waelkens E; Collen D; Persson J; Daha MR; Conway EM
    J Thromb Haemost; 2006 Aug; 4(8):1813-24. PubMed ID: 16879225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways.
    Conway EM; Van de Wouwer M; Pollefeyt S; Jurk K; Van Aken H; De Vriese A; Weitz JI; Weiler H; Hellings PW; Schaeffer P; Herbert JM; Collen D; Theilmeier G
    J Exp Med; 2002 Sep; 196(5):565-77. PubMed ID: 12208873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thrombomodulin lectin-like domain in inflammation.
    Li YH; Kuo CH; Shi GY; Wu HL
    J Biomed Sci; 2012 Mar; 19(1):34. PubMed ID: 22449172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
    Leung LL; Myles T; Nishimura T; Song JJ; Robinson WH
    Mol Immunol; 2008 Oct; 45(16):4080-3. PubMed ID: 18706698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human thrombomodulin regulates complement activation as well as the coagulation cascade in xeno-immune response.
    Kim H; Hawthorne WJ; Kang HJ; Lee YJ; Hwang JI; Hurh S; Ro H; Jeong JC; Cho B; Yang J; Ahn C
    Xenotransplantation; 2015; 22(4):260-72. PubMed ID: 26179123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lectin like domain of thrombomodulin is involved in the defence against pyelonephritis.
    Lattenist L; Teske G; Claessen N; Florquin S; Conway EM; Roelofs JJ
    Thromb Res; 2015 Dec; 136(6):1325-31. PubMed ID: 26573396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition.
    Wang H; Vinnikov I; Shahzad K; Bock F; Ranjan S; Wolter J; Kashif M; Oh J; Bierhaus A; Nawroth P; Kirschfink M; Conway EM; Madhusudhan T; Isermann B
    Thromb Haemost; 2012 Dec; 108(6):1141-53. PubMed ID: 23014597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury.
    Geudens N; Van de Wouwer M; Vanaudenaerde BM; Vos R; Van De Wauwer C; Verleden GM; Verbeken E; Lerut T; Van Raemdonck DE; Conway EM
    Eur Respir J; 2008 Oct; 32(4):862-70. PubMed ID: 18508817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
    Leung LL; Nishimura T; Myles T
    Adv Exp Med Biol; 2008; 632():61-9. PubMed ID: 19025114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
    Mosnier LO
    J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT; Boffa MB
    J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss.
    Cheng TL; Lai CH; Shieh SJ; Jou YB; Yeh JL; Yang AL; Wang YH; Wang CZ; Chen CH; Shi GY; Ho ML; Wu HL
    Sci Rep; 2016 Jun; 6():28340. PubMed ID: 27311356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain.
    Horowitz NA; Blevins EA; Miller WM; Perry AR; Talmage KE; Mullins ES; Flick MJ; Queiroz KC; Shi K; Spek CA; Conway EM; Monia BP; Weiler H; Degen JL; Palumbo JS
    Blood; 2011 Sep; 118(10):2889-95. PubMed ID: 21788337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumonia.
    Schouten M; de Boer JD; van 't Veer C; Roelofs JJ; Meijers JC; Levi M; Conway EM; van der Poll T
    Eur Respir J; 2013 Apr; 41(4):935-42. PubMed ID: 22936703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
    van Moorsel MVA; Poolen GC; Koekman CA; Verhoef S; de Maat S; Barendrecht A; van Kleef ND; Meijers JCM; Schiffelers RM; Maas C; Urbanus RT
    J Thromb Haemost; 2022 May; 20(5):1213-1222. PubMed ID: 35170225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A missense mutation in lectin domain of thrombomodulin causing functional deficiency.
    Jiewen M; Yanyi T; Yuanzheng F; Zhipeng C; Wenyi L; Bei H; Yu H; Tang LV
    Transl Res; 2023 Jan; 251():74-83. PubMed ID: 35921923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.
    Daly C; Qian X; Castanaro C; Pasnikowski E; Jiang X; Thomson BR; Quaggin SE; Papadopoulos N; Wei Y; Rudge JS; Thurston G; Yancopoulos GD; Davis S
    Sci Rep; 2018 Jan; 8(1):505. PubMed ID: 29323190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.
    Wu C; Kim PY; Manuel R; Seto M; Whitlow M; Nagashima M; Morser J; Gils A; Declerck P; Nesheim ME
    J Biol Chem; 2009 Mar; 284(11):7059-67. PubMed ID: 19074424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombomodulin: a multifunctional receptor modulating the endothelial quiescence.
    Giri H; Biswas I; Rezaie AR
    J Thromb Haemost; 2024 Apr; 22(4):905-914. PubMed ID: 38266676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory and anti-fibrinolytic effects of thrombomodulin alfa through carboxypeptidase B2 in the presence of thrombin.
    Tawara S; Sakai T; Matsuzaki O
    Thromb Res; 2016 Nov; 147():72-79. PubMed ID: 27693845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.